CiteSpace-based Visual Analysis of Global Research on Severe Fever with Thrombocytopenia Syndrome (2011—2025)

doi:10.3969/j.issn.1671-2587.2026.04.028

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (4): 653-660.DOI: 10.3969/j.issn.1671-2587.2026.04.028

Previous Articles Next Articles

CiteSpace-based Visual Analysis of Global Research on Severe Fever with Thrombocytopenia Syndrome (2011—2025)

ZHANG Jianing, HAO Lianjun, WANG Yanbin

Hebei Blood Center, Shijiazhuang 050071

Received:2026-07-08 Online:2026-08-20 Published:2026-08-26

Abstract

Abstract: Objective To analyze the global research status, hotspots and frontier trends of severe fever with thrombocytopenia syndrome (SFTS) from 2011 to 2025, reveal the evolutionary context of knowledge in this field, and explore its significance in blood safety assurance. Methods Chinese and English literatures related to SFTS published from 2011 to 2025 were retrieved from the China National Knowledge Infrastructure (CNKI) and Web of Science (WoS) Core Collection databases. Excel was used to analyze the annual publication volume, and CiteSpace 6.3.R1 software was applied to conduct visual analysis and knowledge mapping of national/institutional cooperation networks, journal and literature co-citation networks. Results A total of 1 309 English literatures and 738 Chinese literatures were included in this study. The annual number of publications both at home and abroad showed a significant overall upward trend from 2011 to 2025, with China ranking first globally with 815 publications. Among the core publishing institutions, the top 5 in terms of publication volume and betweenness centrality were concentrated in China, Japan and South Korea. The top 5 most frequently cited literatures also showed high betweenness centrality, and the top 5 journals by citation frequency covered top general medical journals, infectious disease professional journals and open access journals. Keyword clustering and burst analysis revealed that research hotspots and directions differed between domestic and foreign studies. Conclusion Research on SFTS involves multiple fields including epidemiological investigation, etiological mechanism research, clinical treatment, and natural epidemic focus prevention and control. In the future, systematic research on the risk of bloodborne transmission can be carried out to improve the research layout in this field and enhance the comprehensive prevention and control capacity against SFTS transmission risks.

Key words: Servere fever with thrombocytopenia syndrome, Dabie bandavirus, Visual analysis, Knowledge graph, Bibliometrics, Blood safety

CLC Number:

R558.2

ZHANG Jianing, HAO Lianjun, WANG Yanbin. CiteSpace-based Visual Analysis of Global Research on Severe Fever with Thrombocytopenia Syndrome (2011—2025)[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2026, 28(4): 653-660.

References

[1] Yu X J,Liang M F,Zhang S Y,et al.Fever with thrombocytopenia associated with a novel bunyavirus in China[J]. N Engl J Med,2011,364(16):1523-1532.
[2] 国家卫生健康委办公厅,国家中医药局综合司. 发热伴血小板减少综合征诊疗方案(2023年版)[EB/OL].(2023-12-28).https://www.nhc.gov.cn/wjw/c100378/202312/c946629db4454bc3a0766adef06306b7/files/1734003067772_77837.pdf.
[3] Casel M A,Park S J,Choi Y K.Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy[J]. Exp Mol Med, 2021,53(5):713-722.
[4] Liu Q,He B,Huang S Y,et al.Severe fever with thrombocytopenia syndrome,an emerging tick-borne zoonosis[J]. Lancet Infect Dis,2014,14(8):763-772.
[5] Bao C J,Guo X L,Qi X,et al.A family cluster of infections by a newly recognized bunyavirus in Eastern China,2007: further evidence of person-to-person transmission[J]. Clin Infect Dis,2011,53(12):1208-1214.
[6] Moon J,Lee H,Jeon J H,et al.Aerosol transmission of severe fever with thrombocytopenia syndrome virus during resuscitation[J]. Infect Control Hosp Epidemiol, 2019,40(2):238-241.
[7] Yoo J R,Lee K H,Heo S T.Surveillance results for family members of patients with severe fever with thrombocytopenia syndrome[J]. Zoonoses Public Health, 2018,65(8):903-907.
[8] Yang Z D,Hu J G,Lu Q B,et al.The prospective evaluation of viral loads in patients with severe fever with thrombocytopenia syndrome[J]. J Clin Virol,2016, 78:123-128.
[9] 陈秋兰,朱曼桐,陈宁,等. 2011—2021年全国发热伴血小板减少综合征流行特征分析[J]. 中华流行病学杂志, 2022,43(6):852-859.
[10] Kobayashi Y,Kato H,Yamagishi T,et al.Severe fever with thrombocytopenia syndrome,Japan,2013—2017[J]. Emerg Infect Dis,2020,26(4):692-699.
[11] Tran X C,Yun Y,Van An L,et al.Endemic severe fever with thrombocytopenia syndrome,Vietnam[J]. Emerg Infect Dis,2019,25(5):1029-1031.
[12] Win A M,Nguyen Y T H,Kim Y,et al. Genotypic heterogeneity of Orientia tsutsugamushi in scrub typhus patients and thrombocytopenia syndrome co-infection, Myanmar[J]. Emerg Infect Dis,2020,26(8):1878-1881.
[13] Mehand M S,Millett P,Al-Shorbaji F,et al.World health organization methodology to prioritize emerging infectious diseases in need of research and development[J]. Emerg Infect Dis,2018,24(9):e171427.
[14] 孙雨生,仇蓉蓉,邓兴. 国内知识图谱研究进展——基于CiteSpace Ⅱ的分析[J]. 现代情报,2014,34(1):84-88.
[15] 陈超美,陈悦,侯剑华,等. CiteSpace Ⅱ:科学文献中新趋势与新动态的识别与可视化[J]. 情报学报,2009,28(3): 401-421.
[16] Xu B L,Liu L C,Huang X Y,et al.Metagenomic analysis of fever,thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province,China: discovery of a new bunyavirus[J]. PLoS Pathog,2011,7(11):e1002369.
[17] Qin Y,Zhang Q,Liu Y R.Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain[J]. Brain Res Bull,2020,156:15-24.
[18] 陈广,陈韬,舒赛男,等. 重症发热伴血小板减少综合征诊治专家共识[J]. 中华临床感染病杂志,2022,15(4):253-263.
[19] 胡立芬,龚磊,李春辉,等. 发热伴血小板减少综合征感染防控专家共识[J]. 中华疾病控制杂志,2024,28(6):621-628.
[20] 李昱,周航,牟笛,等. 中国2011—2014年发热伴血小板减少综合征流行特征分析[J]. 中华流行病学杂志,2015, 36(6):598-602.
[21] Li H,Lu Q B,Xing B,et al.Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China,2011-17: a prospective observational study[J]. Lancet Infect Dis, 2018,18(10):1127-1137.
[22] 袁春,崔宁,王炳军,等. 253例发热伴血小板减少综合征的临床表现特征[J]. 中国现代医学杂志,2011,21(27):3413-3417.
[23] 柴程良,孙继民,林君芬,等. 浙江省发热伴血小板减少综合征病例临床与流行病学特征分析[J]. 中国预防医学杂志,2012,13(12):904-907.
[24] 曹琛,吴家兵,曹明华,等. 安徽省2011—2015年发热伴血小板减少综合征流行特征分析[J]. 中华疾病控制杂志, 2016,20(8):792-795.
[25] 孙鲁艳,张秀珍,刘葵花,等. 山东省2014—2015年74例发热伴血小板减少综合征流行病学及临床特征[J]. 山东大学学报(医学版),2018,56(12):98-102.
[26] 王晗,赵立凡,孙刚,等. 2012—2021年常州市发热伴血小板减少综合征流行特征及聚集性疫情分析[J]. 寄生虫与医学昆虫学报,2023,30(1):1-5.
[27] 韩英男,刘言,孙钦同,等. 山东省部分地区2020—2021年小兽携带鼠传病原体的调查[J]. 中国媒介生物学及控制杂志,2022,33(6):800-804.
[28] 张乃春,杨红国,徐成,等. 2023—2024年山东省临沂地区发热伴血小板减少综合征患者临床特征与预后分析[J]. 中华实验和临床病毒学杂志,2025,39(4):480-486.
[29] Gai Z T,Liang M F,Zhang Y,et al.Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact[J]. Clin Infect Dis,2012,54(2):249-252.
[30] Jin C,Jiang H,Liang M F,et al.SFTS virus infection in nonhuman Primates[J]. J Infect Dis,2015,211(6):915-925.
[31] Dong S X,Jiao H T,Zhao H,et al.Phylogenetic and genetic evolution analysis of complete SFTSV genome sequences in Shandong Province,China[J]. J Med Virol, 2025,97(3):e70263.
[32] Niu Y X,Liu Y H,Huang L Y,et al.Antiviral immunity of severe fever with thrombocytopenia syndrome: current understanding and implications for clinical treatment[J]. Front Immunol,2024,15:1348836.
[33] Naveed M,Asim M,Aziz T,et al.Development of a broad-spectrum multiepitope vaccine against Dabie bandavirus through immunoinformatic approaches[J]. Int Immunopharmacol,2025,166:115492.
[34] 中华人民共和国卫生部. 发热伴血小板减少综合征防治指南(2010版)[J]. 中华临床感染病杂志,2011,4(4):3990.
[35] 李璐伶,魏亚梅,耿明浩,等. 河北省某市大别班达病毒感染情况及病毒遗传特征分析[J]. 中国人兽共患病学报, 2025,41(8):801-808.
[36] 刘世友,蔡亚男,魏亚梅,等. 2009—2018年河北省病毒性出血热流行态势分析[J]. 中国国境卫生检疫杂志,2020, 43(2):109-112.
[37] 丁培森,刘思雨,邢志磊,等. 基于VOSviewer的甲状腺癌分子与细胞生物学领域的可视化分析[J]. 天津医药, 2024,52(9):985-990.
[38] 李玉杰,徐立然,孟鹏飞,等. 基于CiteSpace与VOSviewer的中医药防治艾滋病领域研究的可视化分析[J]. 职业与健康,2025,41(20):2833-2837.
[39] 吕茜,蔡倩,赵建荣,等. 国内外HIV/AIDS患者血液透析领域研究热点及趋势可视化分析[J]. 职业与健康,2026, 42(5):687-695.

CiteSpace-based Visual Analysis of Global Research on Severe Fever with Thrombocytopenia Syndrome (2011—2025)

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	ZHANG Xiaojuan, ZHANG Ting, YU Yang. Analysis of the Dilemmas in Volunteer Blood Donation in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2026, 28(2): 168-171.
[2]	YANG Jianhao, ZHANG Yi, ZHANG Shunwei, LU Yun, QIU Yingjie. Evaluation of Blood Component Sterility Test Results in the Shanghai Area [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2025, 27(3): 354-359.
[3]	LIU Zhiqing, WANG Dongmei, WANG Yi. Based on WOS Core Database, CiteSpace Global Research Hotspot and Visual Analysis of Human Bone Marrow Mesenchymal Stem Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 797-804.
[4]	WANG Yilai, CHEN Qingkai, HAN Guowei, HE Ziyi. Zika Virus and Blood Safety [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 859-864.
[5]	YANG Jianhao, QIU Yingjie, ZHANG Shunwei, DU Yi, HU Tianyan, XU Bei. Evaluation of Screening Results of Positive Bacteria of Apheresis Platelets in Shanghai [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(4): 499-504.
[6]	LIU Hong, MO Qin, MA Rongna, JIA Yao, WU Xiaofei, WANG Xun. The Effects of Riboflavin Concentrations and Visible Light Intensities on E. Coli in Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(1): 29-34.
[7]	ZHAO Dongyan, SHEN Youhua, TIAN Zhibin, et al. Comparative Analysis of Causes of Deferred Blood Donation between Whole Blood and Aphaeresis Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 388-395.
[8]	CHENG Zhi-xiang, REN Lin, CAO Hong-rong, et al. Haemovigilance for Guideline-based Blood Transfusion Adverse Events [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 48-55.
[9]	DAI Hua-you, LIU Kai-qiang, LIU Xiao-jie, et al. Analysis of Haemovigilance of Adverse Events in Blood Establishments from 2020 to 2021 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(1): 56-62.
[10]	YAN Jun, YIN Wen, ZHANG Kan. Impact of SARS-CoV-2 on Blood Safety [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(3): 232-235.
[11]	WANG Xiang-ping, GUO Jian-bo, DUAN Rong, et al. Analysis of Screening Results by Nucleic Acid Test in Voluntary Blood Donors in Hengyang [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(6): 563-565.
[12]	LIN Jun-tian, LIU Zhi-hua, HE Qi-tong, et al. Analysis of Enzyme Immunoassay Combined with Detection of Nucleic Acid Technology among Voluntary Blood Donors in Foshan [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(6): 569-571.
[13]	LIU Hong-mei，LU Zhi-hao.. Analysis of Syphilis Tests in Unpaid Blood Donors of Fuyang City [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(3): 259-260.
[14]	WANG Yuan-jie，LIU Jia-rui，Li Hong-mei，et al.. Several Problems Should be Paid Attention to in the Application of Electronic Blood Cross Matching [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(3): 308-311.
[15]	LI Peng, GUO Yi. Detection and Analysis of Human Parvovirus B19 Antigens and Antibodies in Methylene Blue Inactivated Virus-free Plasma [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(1): 20-22.